Monica Gandhi, MD, MPH
Professor
Medicine
School of Medicine

at Harvard Medical School and then came to UCSF in 1996 for residency training in Internal Medicine. After her residency, Dr. Gandhi completed a fellowship in Infectious Diseases and a postdoctoral fellowship at the Center for AIDS Prevention Studies, both at UCSF. She also obtained a Masters in Public Health from Berkeley in 2001 with a focus on Epidemiology and Biostatistics.

Dr. Gandhi's current research program is on identifying low-cost solutions to measuring antiretroviral levels in resource-poor settings, such as determining drug levels in hair and urine samples. Dr. Gandhi also works on pre-exposure prophylaxis and treatment strategies for HIV infection in women. .

Dr. Gandhi also has an interest at UCSF in HIV education and mentorship. She also served as the principal investigator of an R24 mentoring grant from the NIH focused on nurturing early career investigators of diversity in HIV research, from which launched the annual "Mentoring the Mentors" workshop for HIV researchers held annually by the UCSF CFAR to train mentors in specialized tools and techniques of effective mentoring. She is also the co-director of the CFAR Network of Integrated Clinical Systems (CNICS) Mentoring Program. She co-directs the HIV/ID Consult Service at San Francisco General Hospital (SFGH), attends on the inpatient HIV/Infectious Diseases consult service, sees patients at Ward 86 as an HIV care provider, and serves as the Associate Director of the UCSF ID fellowship for Clinical Research.

During COVID-19, Dr. Gandhi wrote multiple layman's articles first on ways to mitigate the pandemic through non-pharmaceutical interventions such as face masks and then on the effectiveness of COVID-19 vaccines once available, including the need for global vaccine equity. She wrote on COVID antivirals (Paxlovid, molnupiravir) and monoclonal antibodies. She co-wrote the chapter on COVID-19 epidemiology for the Cecil Goldman Medicine textbook; am co-authoring the chapter on COVID-19 epidemiology and origins for Mandell’s Principles and Practice of Infectious Diseases; and has a book coming out for Mayo Clinic Press on the COVID-19 pandemic called “Endemic: Lessons from HIV for COVID-19” in 2023.

• Feasibility of Implementing a Low-Barrier Long-Acting Injectable Antiretroviral Program for HIV Treatment and Prevention for People Experiencing Homelessness.
  Journal of acquired immune deficiency syndromes (1999) 2024 Mehtani NJ, Strough A, Strieff S, Zevin B, Eveland J, Riley ED, Gandhi M
• Doxycycline to Prevent Sexually Transmitted Infections in Women. Reply.
  The New England journal of medicine 2024 Stewart J, Gandhi M, Bukusi EA
• Rapid Biphasic Decay of Intact and Defective HIV DNA Reservoir During Acute Treated HIV Disease.
  medRxiv : the preprint server for health sciences 2024 Barbehenn A, Shi L, Shao J, Hoh R, Hartig HM, Pae V, Sarvadhavabhatla S, Donaire S, Sheikhzadeh C, Milush J, Laird GM, Mathias M, Ritter K, Peluso M, Martin J, Hecht F, Pilcher C, Cohen SE, Buchbinder…
• Identifying Implementation Determinants and Strategies for Long-Acting Injectable Cabotegravir-Rilpivirine in People with HIV Who Are Virally Unsuppressed.
  Journal of acquired immune deficiency syndromes (1999) 2024 Hickey MD, Grochowski J, Mayorga-Munoz F, Oskarsson J, Imbert E, Spinelli M, Szumowski JD, Appa A, Koester K, Dauria EF, McNulty M, Colasanti J, Havlir DV, Gandhi M, Christopoulos KA
• Low-cost urine tenofovir assay to triage dolutegravir resistance testing.
  The lancet. HIV 2024 Martinson T, Nwogu-Attah J, Spinelli M, Gandhi M
• Point-of-care urine tenofovir monitoring of adherence to drive interventions for HIV treatment and prevention.
  Expert review of molecular diagnostics 2024 Spinelli M, Gandhi M
• Doxycycline Prophylaxis to Prevent Sexually Transmitted Infections in Women.
  The New England journal of medicine 2023 Stewart J, Oware K, Donnell D, Violette LR, Odoyo J, Soge OO, Scoville CW, Omollo V, Mogaka FO, Sesay FA, McClelland RS, Spinelli M, Gandhi M, Bukusi EA, Baeten JM, dPEP Kenya Study Team
• The IMPACT (Infection Management Plus Addiction Care Together) Pilot: A Case Series of Combined Contingency Management for Substance Use Disorders and Antibiotic Adherence in the Hospital Setting.
  Journal of addiction medicine 2023 Appa A, Baral S, Stein B, Knight K, Gandhi M, Coffin P, Martin M
• Post-viral sequelae of COVID-19 and influenza.
  The Lancet. Infectious diseases 2023 Gandhi M
• Interruptions in HIV and Behavioral Health Care for Criminal-Legal Involved People Living with HIV Following Implementation of Decarceration and Shelter in Place in San Francisco, California.
  AIDS and behavior 2023 Clemenzi-Allen AA, Hebert J, Reid MA, Mains T, Hammer H, Gandhi M, Pratt L, Wesson P
• Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled trial.
  The Lancet. Global health 2023 Chamie G, Hahn JA, Kekibiina A, Emenyonu NI, Beesiga B, Marson K, Fatch R, Lodi S, Adong J, Thirumurthy H, McDonell MG, Gandhi M, Bryant K, Havlir DV, Kamya MR, Muyindike WR
• Adherence determination using urine-tenofovir point-of-care testing and pharmacy refill records: A cross-sectional study.
  Medicine 2023 Herbertson EC, Lahiri CD, Olugbake OA, Soremekun RO, Spinelli MA, Gandhi M
• PEPFAR Reauthorization by Congress Urgent for Global Health.
  JAMA 2023 Gandhi M, Goosby E
• Viral Suppression Trajectories Destabilized After Coronavirus Disease 2019 Among US People With Human Immunodeficiency Virus: An Interrupted Time Series Analysis.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2023 Spinelli MA, Christopoulos KA, Moreira CV, Jain JP, Lisha N, Glidden DV, Burkholder GA, Crane HM, Shapiro AE, Jacobson JM, Cachay ER, Mayer KH, Napravnik S, Moore RD, Gandhi M, Johnson MO
• Geographic Mobility and HIV Care Engagement among People Living with HIV in Rural Kenya and Uganda.
  Tropical medicine and infectious disease 2023 Ayieko J, Thorp M, Getahun M, Gandhi M, Maeri I, Gutin SA, Okiring J, Kamya MR, Bukusi EA, Charlebois ED, Petersen M, Havlir DV, Camlin CS, Murnane PM
• Detection of Antiretrovirals in Transgender Women With HIV Is Not Altered by Hair Treatments.
  Journal of acquired immune deficiency syndromes (1999) 2023 Rodriguez VJ, Alcaide ML, Sued O, Aristegui I, Radusky PD, Kozlova S, Cardozo N, Dell'Isola E, Gandhi M, Jones DL
• Dynamic choice HIV prevention intervention at outpatient departments in rural Kenya and Uganda.
  AIDS (London, England) 2023 Koss CA, Ayieko J, Kabami J, Balzer LB, Kakande E, Sunday H, Nyabuti M, Wafula E, Shade SB, Biira E, Opel F, Atuhaire HN, Okochi H, Ogachi S, Gandhi M, Bacon MC, Bukusi EA, Chamie G, Petersen ML, …
• Association of SARS-CoV-2 Infection and Cardiopulmonary Long COVID With Exercise Capacity and Chronotropic Incompetence Among People With HIV.
  Journal of the American Heart Association 2023 Durstenfeld MS, Peluso MJ, Spinelli MA, Li D, Hoh R, Chenna A, Yee B, Winslow J, Petropoulos C, Gandhi M, Henrich TJ, Aras MA, Long CS, Deeks SG, Hsue PY
• Accelerating Research Careers in Science Through Early Mentored Research Experiences for Undergraduates and Masters' Students at the University of California, San Francisco Center for AIDS Research.
  Journal of acquired immune deficiency syndromes (1999) 2023 Sauceda JA, Watabe J, Sterling L, Fuchs J, Parangan-Smith A, Uwaezuoke K, Gandhi M, Marquez C
• Urine point-of-care tenofovir test demonstrates strong predictive clinical and research utility.
  AIDS (London, England) 2023 Mustanski B, Ryan DT, Spinelli MA, Gandhi M, Newcomb ME
• Diagnostic accuracy of a point-of-care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz-based antiretroviral therapy.
  Journal of the International AIDS Society 2023 Dorward J, Lessells R, Govender K, Moodley P, Samsunder N, Sookrajh Y, Turner P, Butler CC, Hayward G, Gandhi M, Drain PK, Garrett N
• Factors that influence adolescent girls and young women's re-initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa.
  Journal of the International AIDS Society 2023 de Vos L, Mudzingwa EK, Fynn L, Atujuna M, Mugore M, Gandhi M, Celum C, Hosek S, Bekker LG, Daniels J, Medina-Marino A
• Pandemic expertise: qualitative findings on the experiences of living with HIV during the COVID-19 pandemic.
  AIDS care 2023 Mars SG, Spinelli MA, Ondocsin J, Koester KA, Rodriguez ES, Jain J, Arreguin M, Johnson MO, Gandhi M
• Cardiovascular health among persons with HIV without existing atherosclerotic cardiovascular disease.
  AIDS (London, England) 2023 McLaughlin MM, Durstenfeld MS, Gandhi M, Greene M, Ma Y, Beatty AL, Hsue PY
• Global HIV control: is the glass half empty or half full?
  The lancet. HIV 2023 Nachega JB, Musoke P, Kilmarx PH, Gandhi M, Grinsztejn B, Pozniak A, Rawat A, Wilson L, Mills EJ, Altice FL, Mellors JW, Quinn TC
• Projected Benefits of Long-Acting Antiretroviral Therapy in Nonsuppressed People With Human Immunodeficiency Virus Experiencing Adherence Barriers.
  Open forum infectious diseases 2023 Chen W, Gandhi M, Sax PE, Neilan AM, Garland WH, Wilkin T, Cohen R, Ciaranello AL, Kulkarni SP, Eron J, Freedberg KA, Hyle EP
• Demonstration Project of Long-Acting Antiretroviral Therapy in a Diverse Population of People With HIV.
  Annals of internal medicine 2023 Gandhi M, Hickey M, Imbert E, Grochowski J, Mayorga-Munoz F, Szumowski JD, Oskarsson J, Shiels M, Sauceda J, Salazar J, Dilworth S, Nguyen JQ, Glidden DV, Havlir DV, Christopoulos KA
• Benefits and limitations of different study designs for long-acting antiretroviral therapy among people living with HIV with viremia.
  Journal of the International AIDS Society 2023 Gandhi M, Nachega J, Miller V, Wilkin T
• Mass spectrometry imaging of hair identifies daily maraviroc adherence in HPTN 069/ACTG A5305.
  PloS one 2023 Rosen EP, White N, Gilliland WM, Gerona RR, Gandhi M, Amico KR, Mayer KH, Gulick RM, Kashuba ADM
• Feasibility and acceptability of peer-delivered HIV self-testing and PrEP for young women in Kampala, Uganda.
  BMC public health 2023 Nakalega R, Mukiza N, Menge R, Kizito S, Babirye JA, Kuteesa CN, Mawanda D, Mulumba E, Nabukeera J, Ggita J, Nakanjako L, Akello C, Mirembe BG, Lukyamuzi Z, Nakaye C, Kataike H, Maena J, Etima J, …
• Association of SARS-CoV-2 Infection and Cardiopulmonary Long COVID with Exercise Capacity and Chronotropic Incompetence among People with HIV.
  medRxiv : the preprint server for health sciences 2023 Durstenfeld MS, Peluso MJ, Spinelli MA, Li D, Hoh R, Gandhi M, Henrich TJ, Aras MA, Long CS, Deeks SG, Hsue PY
• The intertwined epidemics of HIV and COVID-19 - emerging data and responses.
  Current opinion in HIV and AIDS 2023 Spinelli M, Gandhi M, Riva A
• A Position Statement on Mpox as a Sexually Transmitted Disease.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2023 Allan-Blitz LT, Gandhi M, Adamson P, Park I, Bolan G, Klausner JD
• Long-acting antiretrovirals and HIV treatment adherence.
  The lancet. HIV 2023 Nachega JB, Scarsi KK, Gandhi M, Scott RK, Mofenson LM, Archary M, Nachman S, Decloedt E, Geng EH, Wilson L, Rawat A, Mellors JW
• Lessons Learned From the Implementation of a Pilot Study on Self-collected Specimen Return by Sexual Minority Men (Project Caboodle!): Qualitative Exploration.
  JMIR formative research 2023 Sallabank G, Stephenson R, Gandhi M, Merrill L, Sharma A
• PrEPare for Work: A Pilot Randomized Controlled Trial of an Intervention to Optimize HIV PrEP Outcomes Among Male Sex Workers.
  AIDS and behavior 2023 Biello KB, Chan PA, Holcomb R, Ndoye CD, Valente PK, Maynard M, Gandhi M, Mayer KH, Mimiaga MJ
• Alternative Methods for Therapeutic Drug Monitoring and Dose Adjustment of Tuberculosis Treatment in Clinical Settings: A Systematic Review.
  Clinical pharmacokinetics 2023 Rao PS, Modi N, Nguyen NT, Vu DH, Xie YL, Gandhi M, Gerona R, Metcalfe J, Heysell SK, Alffenaar JC
• Urine Tenofovir Levels Strongly Correlate With Virologic Suppression in Patients With Human Immunodeficiency Virus on Tenofovir Alafenamide-Based Antiretroviral Therapy.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2023 Johnson KA, Okochi H, Arreguin M, Watabe J, Glidden DV, Chattopadhyay A, Imbert E, Hickey MD, Gandhi M, Spinelli M
• Point-of-care urine tenofovir testing to predict HIV drug resistance among individuals with virologic failure.
  AIDS (London, England) 2023 McCluskey SM, Govender K, Adamson J, Gandhi M, Spinelli MA, Moosa MY, Muyindike W, Moodley P, Pillay M, Masette G, Sunpath H, Pillay S, Chen G, Hedt-Gauthier B, Marconi VC, Siedner MJ
• Perspectives of people living with HIV and health workers about a point-of-care adherence assay: a qualitative study on acceptability.
  AIDS care 2023 Mcinziba A, Wademan D, Viljoen L, Myburgh H, Jennings L, Decloedt E, Orrell C, van Zyl G, van Schalkwyk M, Gandhi M, Hoddinott G
• First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable Human Immunodeficiency Virus (HIV) Viremia in an Urban HIV Clinic.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2023 Christopoulos KA, Grochowski J, Mayorga-Munoz F, Hickey MD, Imbert E, Szumowski JD, Dilworth S, Oskarsson J, Shiels M, Havlir D, Gandhi M
• 1406. IMPACT ( Infection Management Plus Addiction Care Together ): A Combined Contingency Management Pilot for Substance Use Disorders & Antibiotic Adherence in the Acute Care Setting.
  Open Forum Infectious Diseases 2022 Ayesha Ashley Appa, Brianna Stein, Stefan Baral, Kelly Knight, Monica Gandhi, Phillip Coffin, Marlene Martin
• Contingency Management for Integrated Harm Reduction Among Men Who Have Sex with Men Who Use Methamphetamine in Los Angeles: A Pilot Assessment.
  AIDS and behavior 2022 Blair CS, Gandhi M, Shoptaw S, Blades C, Clark JL
• New boosters are here! Who should receive them and when?
  The Lancet. Infectious diseases 2022 Doron S, Gandhi M
• Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022 Scully EP, Aga E, Tsibris A, Archin N, Starr K, Ma Q, Morse GD, Squires KE, Howell BJ, Wu G, Hosey L, Sieg SF, Ehui L, Giguel F, Coxen K, Dobrowolski C, Gandhi M, Deeks S, Chomont N, Connick E, …
• HIV Treatment Outcomes in POP-UP: Drop-in HIV Primary Care Model for People Experiencing Homelessness.
  The Journal of infectious diseases 2022 Hickey MD, Imbert E, Appa A, Del Rosario JB, Lynch E, Friend J, Avila R, Clemenzi-Allen A, Riley ED, Gandhi M, Havlir DV
• Agreement Between Measures of Adherence to Isoniazid Preventive Therapy Among People With HIV in Uganda.
  Open forum infectious diseases 2022 Forman LS, Lodi S, Fatch R, Emenyonu NI, Adong J, Ngabirano C, Jacobson KR, Gerona R, Reckers AR, Gandhi M, Muyindike WR, Hahn JA
• Perceptions and Experiences of Returning Self-collected Specimens for HIV, Bacterial STI and Potential PrEP Adherence Testing among Sexual Minority Men in the United States.
  AIDS and behavior 2022 Sharma A, Gandhi M, Sallabank G, Merrill L, Stephenson R
• Differences in Post-mRNA Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) Concentrations and Surrogate Virus Neutralization Test Response by Human Immunodeficiency Virus (HIV) Status and Type of Vaccine: A Matched Case-Control Observational Study.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022 Spinelli MA, Peluso MJ, Lynch KL, Yun C, Glidden DV, Henrich TJ, Deeks SG, Gandhi M
• Immunity Against the Omicron Variant From Vaccination, Recovery, or Both.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022 Gandhi M
• Impact of Multicomponent Support Strategies on Human Immunodeficiency Virus Virologic Suppression Rates During Coronavirus Disease 2019: An Interrupted Time Series Analysis.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022 Spinelli MA, Le Tourneau N, Glidden DV, Hsu L, Hickey MD, Imbert E, Arreguin M, Jain JP, Oskarsson JJ, Buchbinder SP, Johnson MO, Havlir D, Christopoulos KA, Gandhi M
• Antiretroviral Therapy Adherence During and Postbreastfeeding Cessation Measured by Tenofovir Levels in Hair.
  Journal of acquired immune deficiency syndromes (1999) 2022 Nematadzira TG, Murnane PM, Odiase OJ, Bacchetti P, Okochi H, Tallerico R, Chanaiwa VM, Vhembo T, Mutambanengwe-Jacob MT, Louie A, Chipato T, Gandhi M, Stranix-Chibanda L, IMPAACT PROMISE Study Team
• Tenofovir-Diphosphate in Dried Blood Spots vs Tenofovir in Urine/Plasma for Oral Preexposure Prophylaxis Adherence Monitoring.
  Open forum infectious diseases 2022 Niu X, Kubiak RW, Siriprakaisil O, Klinbuyaem V, Sukrakanchana PO, Cressey R, Okochi H, Gandhi M, Cressey TR, Drain PK
• Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens.
  AIDS (London, England) 2022 van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, van Schalkwyk M, Spinelli M, Decloedt E, Orrell C, Gandhi M
• COVID-19 Outcomes and Risk Factors Among People Living with HIV.
  Current HIV/AIDS reports 2022 Spinelli MA, Jones BLH, Gandhi M
• Brief Report: Use of Remnant Specimens to Assess Use of HIV PrEP Among Populations With Risk of HIV Infection: A Novel Approach.
  Journal of acquired immune deficiency syndromes (1999) 2022 Pathela P, Qasmieh S, Gandhi M, Rozen E, Okochi H, Goldstein H, Herold BC, Jamison K, Schillinger JA, Nash D
• Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection.
  AIDS (London, England) 2022 Peluso MJ, Spinelli MA, Deveau TM, Forman CA, Munter SE, Mathur S, Tang AF, Lu S, Goldberg SA, Arreguin MI, Hoh R, Tai V, Chen JY, Martinez EO, Yee BC, Chenna A, Winslow JW, Petropoulos CJ, Sette A, …
• Comparison of efavirenz levels in blood and hair with pharmacy refills as measures of adherence and predictors of viral suppression among people living with HIV in Nigeria.
  AIDS research and therapy 2022 Nwogu JN, Ngene SO, Babalola CP, Olagunju A, Owen A, Khoo SH, Kotila OA, Berzins B, Okochi H, Tallerico R, Gandhi M, Taiwo B
• Study Evaluating Self-Collected Specimen Return for HIV, Bacterial STI, and Potential Pre-Exposure Prophylaxis Adherence Testing Among Sexual Minority Men in the United States.
  American journal of men's health 2022 Sharma A, Gandhi M, Sallabank G, Merrill L, Stephenson R
• Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label randomized trial.
  Trials 2022 Stewart J, Bukusi E, Sesay FA, Oware K, Donnell D, Soge OO, Celum C, Odoyo J, Kwena ZA, Scoville CW, Violette LR, Morrison S, Simoni J, McClelland RS, Barnabas R, Gandhi M, Baeten JM
• Testing a social network approach to promote HIV self-testing and linkage to care among fishermen at Lake Victoria: study protocol for the Owete cluster randomized controlled trial.
  Trials 2022 Sheira LA, Kwena ZA, Charlebois ED, Agot K, Ayieko B, Gandhi M, Bukusi EA, Thirumurthy H, Camlin CS
• Brief Report: Heterogeneous Preferences for Care Engagement Among People With HIV Experiencing Homelessness or Unstable Housing During the COVID-19 Pandemic.
  Journal of acquired immune deficiency syndromes (1999) 2022 Imbert E, Hickey MD, Del Rosario JB, Conte M, Kerkhoff AD, Clemenzi-Allen A, Riley ED, Havlir DV, Gandhi M
• Relationship Dynamics are Associated with Self-Reported Adherence but not an Objective Adherence Measure in Malawi.
  AIDS and behavior 2022 Conroy AA, McKenna S, Ruark A, Neilands TB, Spinelli M, Gandhi M
• Geriatric conditions and healthcare utilisation in older adults living with HIV.
  Age and ageing 2022 Greene M, Shi Y, Boscardin J, Sudore R, Gandhi M, Covinsky K
• Self-Reported Use of HIV Preexposure Prophylaxis Is Highly Accurate Among Sexual Health Clinic Patients in New York City.
  Sexually transmitted diseases 2022 Qasmieh S, Nash D, Gandhi M, Rozen E, Okochi H, Goldstein H, Herold BC, Jamison K, Pathela P
• Distinct forms of migration and mobility are differentially associated with HIV treatment adherence.
  AIDS (London, England) 2022 Murnane PM, Gandhi M, Bacchetti P, Getahun M, Gutin SA, Okochi H, Maeri I, Eyul P, Omoding D, Okiring J, Tallerico R, Louie A, Akullian A, Kamya MR, Bukusi EA, Charlebois ED, Camlin CS
• Equity in access to long-acting injectables in the USA.
  The lancet. HIV 2022 Hojilla JC, Gandhi M, Satre DD, Johnson MO, Saberi P
• Drug Resistance, Rather than Low Tenofovir Levels in Blood or Urine, Is Associated with Tenofovir, Emtricitabine, and Efavirenz Failure in Resource-Limited Settings.
  AIDS research and human retroviruses 2021 Jennings L, Kellermann T, Spinelli M, Nkantsu Z, Cogill D, van Schalkwyk M, Decloedt E, van Zyl G, Orrell C, Gandhi M
• Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement.
  Open forum infectious diseases 2021 Peluso MJ, Kelly JD, Lu S, Goldberg SA, Davidson MC, Mathur S, Durstenfeld MS, Spinelli MA, Hoh R, Tai V, Fehrman EA, Torres L, Hernandez Y, Williams MC, Arreguin MI, Ngo LH, Deswal M, Munter SE, …
• Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and Recovery.
  International journal of behavioral medicine 2021 Santiago-Rodriguez EI, Maiorana A, Peluso MJ, Hoh R, Tai V, Fehrman EA, Hernandez Y, Torres L, Spinelli MA, Gandhi M, Kelly JD, Martin JN, Henrich TJ, Deeks SG, Sauceda JA
• COVID-19 Vaccine Hesitancy Among PLWH in South India: Implications for Vaccination Campaigns.
  Journal of acquired immune deficiency syndromes (1999) 2021 Ekstrand ML, Heylen E, Gandhi M, Steward WT, Pereira M, Srinivasan K
• Machine Learning Algorithms Using Routinely Collected Data Do Not Adequately Predict Viremia to Inform Targeted Services in Postpartum Women Living With HIV.
  Journal of acquired immune deficiency syndromes (1999) 2021 Murnane PM, Ayieko J, Vittinghoff E, Gandhi M, Katumbi C, Milala B, Nakaye C, Kanda P, Moodley D, Nyati ME, Loftis AJ, Fowler MG, Flynn P, Currier JS, Cohen CR
• LB8. Lower SARS-CoV-2 IgG and Pseudovirus Neutralization Titers Post-mRNA Vaccination among People Living with HIV.
  Open Forum Infectious Diseases 2021 Matthew A Spinelli, Michael J Peluso, Kara Lynch, Cassandra Yun, David V Glidden, Timothy J Henrich, Steve Deeks, Monica Gandhi
• SARS-CoV-2 incidence, testing rates, and severe COVID-19 outcomes among people with and without HIV.
  AIDS (London, England) 2021 Spinelli MA, Brown LB, Glidden DV, Hunter K, Martin-Tuite P, Zheng J, Sera C, Havlir D, Buchbinder SP, Gandhi M
• Revisiting COVID-19 policies: 10 evidence-based recommendations for where to go from here.
  BMC public health 2021 Halperin DT, Hearst N, Hodgins S, Bailey RC, Klausner JD, Jackson H, Wamai RG, Ladapo JA, Over M, Baral S, Escandón K, Gandhi M
• Examining the Impact of the Golden Compass Clinical Care Program for Older People with HIV: A Qualitative Study.
  AIDS and behavior 2021 Tan JY, Greene M, Blat C, Albers A, Grochowski J, Oskarsson J, Shiels M, Hsue P, Havlir D, Gandhi M, Myers J
• The impact of COVID-19 on mentoring early-career investigators: "Everything can wait. Listen more than usual and share your own struggles".
  Medicine 2021 Johnson MO, Gandhi M, Fuchs JD, Sterling L, Sauceda JA, Saag MS, Riley ED, Sevelius JM
• Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes.
  BMJ open 2021 Bardon AR, Dorward J, Sookrajh Y, Sayed F, Quame-Amaglo J, Pillay C, Feutz E, Ngobese H, Simoni JM, Sharma M, Cressey TR, Gandhi M, Lessells R, Moodley P, Naicker N, Naidoo K, Thomas K, Celum C, …
• Associations between efavirenz concentrations, pharmacogenetics and neurocognitive performance in people living with HIV in Nigeria.
  AIDS (London, England) 2021 Nwogu JN, Gandhi M, Owen A, Khoo SH, Taiwo B, Olagunju A, Berzins B, Okochi H, Tallerico R, Robertson K, Babalola CP
• Brief Report: Ritonavir Concentrations in Hair Predict Virologic Outcomes in HIV-Infected Adolescents With Virologic Failure on Atazanavir-Based or Ritonavir-Based Second-Line Treatment.
  Journal of acquired immune deficiency syndromes (1999) 2021 Chawana TD, Nhachi CFB, Nathoo K, Ngara B, Okochi H, Louie A, Kuncze K, Katzenstein D, Metcalfe J, Gandhi M, Adolescent Treatment Failure (ATF) Study Team
• A Qualitative Study of the Experience of Immediate Antiretroviral Therapy Among Urban Persons With Newly Diagnosed Human Immunodeficiency Virus.
  Open forum infectious diseases 2021 Christopoulos KA, Erguera XA, VanderZanden L, Campbell C, Green M, Tsuzuki MD, Schneider J, Coffey S, Bacon O, Gandhi M, Koester KA
• Brief Report: No Difference in Urine Tenofovir Levels in Patients Living With HIV on Unboosted Versus Dose-Adjusted Boosted Tenofovir Alafenamide.
  Journal of acquired immune deficiency syndromes (1999) 2021 Johnson KA, Okochi H, Glidden DV, Gandhi M, Spinelli M
• Preferences for Conditional Economic Incentives to Improve Pre-exposure Prophylaxis Adherence: A Discrete Choice Experiment Among Male Sex Workers in Mexico.
  AIDS and behavior 2021 Salinas-Rodríguez A, Sosa-Rubí SG, Chivardi C, Rodríguez-Franco R, Gandhi M, Mayer KH, Operario D, Gras-Allain N, Vargas-Guadarrama G, Galárraga O
• Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
  Cell reports 2021 Peluso MJ, Deitchman AN, Torres L, Iyer NS, Munter SE, Nixon CC, Donatelli J, Thanh C, Takahashi S, Hakim J, Turcios K, Janson O, Hoh R, Tai V, Hernandez Y, Fehrman EA, Spinelli MA, Gandhi M, Trinh L,…
• Effectiveness of Adding a Mask Recommendation to Other Public Health Measures.
  Annals of internal medicine 2021 Spinelli MA, Glidden DV, Gennatas ED, Rutherford GW, Gandhi M
• Predictors of Peripapillary and Macular Optical Microangiography Measurements in Healthy Eyes.
  Journal of glaucoma 2021 Bansal T, Dubey S, Rao HL, Gandhi M, Pegu J
• Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Disproportionately Affects the Latinx Population During Shelter-in-Place in San Francisco.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021 Chamie G, Marquez C, Crawford E, Peng J, Petersen M, Schwab D, Schwab J, Martinez J, Jones D, Black D, Gandhi M, Kerkhoff AD, Jain V, Sergi F, Jacobo J, Rojas S, Tulier-Laiwa V, Gallardo-Brown T, Appa…
• SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
  Science advances 2021 Peluso MJ, Takahashi S, Hakim J, Kelly JD, Torres L, Iyer NS, Turcios K, Janson O, Munter SE, Thanh C, Donatelli J, Nixon CC, Hoh R, Tai V, Fehrman EA, Hernandez Y, Spinelli MA, Gandhi M, Palafox MA, …
• Pilot Randomized Controlled Trial of Motivational Interviewing with Sexual Minority Male Couples to Reduce Drug Use and Sexual Risk: The Couples Health Project.
  AIDS and behavior 2021 Starks TJ, Adebayo T, Kyre KD, Millar BM, Stratton MJ, Gandhi M, Ingersoll KS
• Antiretroviral hair levels, self-reported adherence, and virologic failure in second-line regimen patients in resource-limited settings.
  AIDS (London, England) 2021 Apornpong T, Grinsztejn B, Hughes M, Ritz J, Kerr SJ, Fletcher CV, Ruxrungtham K, Godfrey C, Gross R, Hogg E, Wallis CL, Badal-Faesen S, Hosseinipour MC, Mngqbisa R, Santos BR, Shah S, Hovind LJ, …
• Tenofovir-based PrEP for COVID-19: an untapped opportunity?
  AIDS (London, England) 2021 DeJong C, Spinelli MA, Okochi H, Gandhi M
• Evaluation of the POP-UP programme: a multicomponent model of care for people living with HIV with homelessness or unstable housing.
  AIDS (London, England) 2021 Imbert E, Hickey MD, Clemenzi-Allen A, Lynch E, Friend J, Kelley J, Conte M, Das D, Rosario JBD, Collins E, Oskarsson J, Hicks ML, Riley ED, Havlir DV, Gandhi M
• A combined assay for quantifying remdesivir and its metabolite, along with dexamethasone, in serum.
  The Journal of antimicrobial chemotherapy 2021 Reckers A, Wu AHB, Ong CM, Gandhi M, Metcalfe J, Gerona R
• Coronavirus Disease 2019 (COVID-19) and HIV Spotlight the United States Imperative for Permanent Affordable Housing.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021 Riley ED, Hickey MD, Imbert E, Clemenzi-Allen AA, Gandhi M
• Use of Drug-level Testing and Single-genome Sequencing to Unravel a Case of Human Immunodeficiency Virus Seroconversion on Pre-exposure Prophylaxis.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021 Spinelli MA, Lowery B, Shuford JA, Spindler J, Kearney MF, McFarlane JR, McDonald C, Okochi H, Phung N, Kuncze K, Jee K, Johannessen D, Anderson PL, Smith DK, Defechereux P, Grant RM, Gandhi M
• The Drinkers' Intervention to Prevent Tuberculosis (DIPT) trial among heavy drinkers living with HIV in Uganda: study protocol of a 2×2 factorial trial.
  Trials 2021 Lodi S, Emenyonu NI, Marson K, Kwarisiima D, Fatch R, McDonell MG, Cheng DM, Thirumurthy H, Gandhi M, Camlin CS, Muyindike WR, Hahn JA, Chamie G
• Adjudicating Reasons for Hospitalization Reveals That Severe Illness From COVID-19 in Children Is Rare.
  Hospital pediatrics 2021 Beck A, Gandhi M
• Operationalizing Human Immunodeficiency Virus Cure-related Trials with Analytic Treatment Interruptions During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: A Collaborative Approach.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021 Peluso MJ, Dee L, Shao S, Taylor J, Campbell D, Collins S, Gandhi M, Johnston R, Deeks SG, Sauceda JA, Dubé K
• Drug Overdose Deaths Before and After Shelter-in-Place Orders During the COVID-19 Pandemic in San Francisco.
  JAMA network open 2021 Appa A, Rodda LN, Cawley C, Zevin B, Coffin PO, Gandhi M, Imbert E
• Blueprints Clinical Cases in Medicine
  Blueprints Clinical Cases in Medicine. 2021 Gandhi M, Bacon O, and AB Caughey.
• SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study.
  The lancet. HIV 2021 Spinelli MA, Lynch KL, Yun C, Glidden DV, Peluso MJ, Henrich TJ, Gandhi M, Brown LB
• Point-of-Care Test for Assessing Tenofovir Adherence: Feasibility and Recommendations from Women in an Oral PrEP Program in Kenya and Their Healthcare Providers.
  AIDS and behavior 2021 Thuo N, Polay M, Leddy AM, Ngure K, Chatterhee P, Gandhi M, Amico KR
• Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care Testing.
  Open forum infectious diseases 2021 Johnson KA, Niu X, Glidden DV, Castillo-Mancilla JR, Yager J, MaWhinney S, Morrow M, Okochi H, Cressey TR, Drain PK, Gandhi M, Anderson PL, Spinelli MA
• High Acceptability of Donating Hair and Other Biological Samples for Research Among People Living with HIV in an Outpatient Clinic in Lagos, Nigeria.
  AIDS research and human retroviruses 2021 Herbertson EC, Lahiri CD, Nwogu JN, Soremekun RO, Olugbake OA, Ezechi OC, Akanmu AS, Gandhi M
• Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases - Authors' reply.
  The Lancet. Infectious diseases 2021 Spinelli MA, Rutherford G, Gandhi M
• Tenofovir and emtricitabine concentrations in hair are comparable between individuals on tenofovir disoproxil fumarate versus tenofovir alafenamide-based ART.
  Drug testing and analysis 2021 Okochi H, Louie A, Phung N, Zhang K, Tallerico RM, Kuncze K, Spinelli MA, Koss CA, Benet LZ, Gandhi M
• Masks Reduce Viral Inoculum of SARS-CoV2.
  Journal of general internal medicine 2021 Gandhi M, Beyrer C, Goosby E
• Characterizing the COVID-19 illness experience to inform the study of post-acute sequelae and recovery: a qualitative study.
  medRxiv : the preprint server for health sciences 2021 Santiago-Rodriguez EI, Maiorana A, Peluso MJ, Hoh R, Tai V, Fehrman EA, Hernandez Y, Torres L, Spinelli MA, Gandhi M, Kelly JD, Martin JN, Henrich TJ, Deeks SG, Sauceda JA
• Disparities in Integrase Inhibitor Usage in the Modern HIV Treatment Era: A Population-Based Study in a US City.
  Open forum infectious diseases 2021 Spinelli MA, Hessol NA, Schwarcz SK, Scheer S, Gandhi M, Chin Hsu L
• A mentor training workshop focused on fostering diversity engenders lasting impact on mentoring techniques: Results of a long-term evaluation.
  Journal of clinical and translational science 2021 Johnson MO, Fuchs JD, Sterling L, Sauceda JA, Saag MS, Fernandez A, Evans CH, Gandhi M
• Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19.
  medRxiv : the preprint server for health sciences 2021 Peluso MJ, Kelly JD, Lu S, Goldberg SA, Davidson MC, Mathur S, Durstenfeld MS, Spinelli MA, Hoh R, Tai V, Fehrman EA, Torres L, Hernandez Y, Williams MC, Arreguin MI, Bautista JA, Ngo LH, Deswal M, …
• SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
  medRxiv : the preprint server for health sciences 2021 Peluso MJ, Takahashi S, Hakim J, Kelly JD, Torres L, Iyer NS, Turcios K, Janson O, Munter SE, Thanh C, Nixon CC, Hoh R, Tai V, Fehrman EA, Hernandez Y, Spinelli MA, Gandhi M, Palafox MA, Vallari A, …
• Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19.
  medRxiv : the preprint server for health sciences 2021 Peluso MJ, Deitchman AN, Torres L, Iyer NS, Nixon CC, Munter SE, Donatelli J, Thanh C, Takahashi S, Hakim J, Turcios K, Janson O, Hoh R, Tai V, Hernandez Y, Fehrman E, Spinelli MA, Gandhi M, Trinh L, …
• Viral suppression during COVID-19 among people with HIV experiencing homelessness in a low-barrier clinic-based program.
  AIDS (London, England) 2021 Hickey MD, Imbert E, Glidden DV, Del Rosario JB, Chong M, Clemenzi-Allen A, Oskarsson J, Riley ED, Gandhi M, Havlir DV
• Extent of In Utero Transfer of Tenofovir From Mother to Fetus: A Paired Analysis of Hair Specimens Collected at Birth From a Cohort in the United States.
  The Journal of infectious diseases 2021 Pintye J, Huo Y, Kacanek D, Zhang K, Kuncze K, Okochi H, Gandhi M
• Short Communication: Higher Tenofovir Concentrations in Hair Are Associated with Decreases in Viral Load and Not Self-Reported Adherence in HIV-Infected Adolescents with Second-Line Virological Treatment Failure.
  AIDS research and human retroviruses 2021 Chawana T, Nhachi C, Nathoo K, Ngara B, Okochi H, Louie A, Kuncze K, Katzenstein D, Metcalfe J, Gandhi M
• COVID-19 Mitigation With Appropriate Safety Measures in an Essential Workplace: Lessons for Opening Work Settings in the United States During COVID-19.
  Open forum infectious diseases 2021 Haigh KZ, Gandhi M
• Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity.
  The Lancet. Infectious diseases 2021 Spinelli MA, Glidden DV, Gennatas ED, Bielecki M, Beyrer C, Rutherford G, Chambers H, Goosby E, Gandhi M
• HIV and women in the USA: what we know and where to go from here.
  Lancet (London, England) 2021 Adimora AA, Ramirez C, Poteat T, Archin NM, Averitt D, Auerbach JD, Agwu AL, Currier J, Gandhi M
• HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda.
  PLoS medicine 2021 Koss CA, Havlir DV, Ayieko J, Kwarisiima D, Kabami J, Chamie G, Atukunda M, Mwinike Y, Mwangwa F, Owaraganise A, Peng J, Olilo W, Snyman K, Awuonda B, Clark TD, Black D, Nugent J, Brown LB, Marquez C,…
• Detectable HIV RNA in late pregnancy associated with low tenofovir hair levels at time of delivery among women living with HIV in the United States.
  AIDS (London, England) 2021 Pintye J, Huo Y, Kacanek D, Zhang K, Kuncze K, Okochi H, Gandhi M, Pediatric HIV/AIDS Cohort Study (PHACS)
• Urine Tenofovir Levels Measured Using a Novel Immunoassay Predict Human Immunodeficiency Virus Protection.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021 Stalter RM, Baeten JM, Donnell D, Spinelli MA, Glidden DV, Rodrigues WC, Wang G, Vincent M, Mugo N, Mujugira A, Marzinke M, Hendrix C, Gandhi M, Partners PrEP Study Team
• Diagnostic accuracy of a liquid chromatography-tandem mass spectrometry assay in small hair samples for rifampin-resistant tuberculosis drug concentrations in a routine care setting.
  BMC infectious diseases 2021 Metcalfe J, Bacchetti P, Esmail A, Reckers A, Aguilar D, Wen A, Huo S, Muyindike WR, Hahn JA, Dheda K, Gandhi M, Gerona R
• COVID-19 Susceptibility and Outcomes Among People Living With HIV in San Francisco.
  Journal of acquired immune deficiency syndromes (1999) 2021 Sachdev D, Mara E, Hsu L, Scheer S, Rutherford G, Enanoria W, Gandhi M
• The interplay between HIV and COVID-19: summary of the data and responses to date.
  Current opinion in HIV and AIDS 2021 Brown LB, Spinelli MA, Gandhi M
• TransPrEP: Results from the Pilot Study of a Social Network-Based Intervention to Support PrEP Adherence Among Transgender Women in Lima, Peru.
  AIDS and behavior 2021 Clark J, Reisner S, Perez-Brumer A, Huerta L, Sanchez H, Moriarty K, Luque MM, Okochi H, Salazar X, Mimiaga M, Sanchez J, Gandhi M, Mayer KH, Lama JR
• 448. Disproportionate Burden of COVID-19 on Latinx Residents among Hospitalized Patients at San Francisco’s Public Health Hospital.
  Open Forum Infectious Diseases 2020 Vivek Jain, Lillian B Brown, Carina Marquez, Luis Rubio, Natasha Spottiswoode, Bethlehem Churnet, Katherine Brooks, Mengyu Zhou, Timothy Muldoon, Carolyn Hendrickson, Adithya Cattamanchi, Antonio …
• Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control COVID-19.
  2020 Monica Gandhi, Deborah S Yokoe, Diane V. Havlir
• Pragmatic randomized trial of a pre-visit intervention to improve the quality of telemedicine visits for vulnerable patients living with HIV.
  Journal of telemedicine and telecare 2020 Hickey MD, Sergi F, Zhang K, Spinelli MA, Black D, Sola C, Blaz V, Nguyen JQ, Oskarsson J, Gandhi M, Havlir DV
• Uniting Infectious Disease and Physical Science Principles on the Importance of Face Masks for COVID-19.
  Med (New York, N.Y.) 2020 Gandhi M, Marr LC
• Development and validation of a liquid chromatography-tandem mass spectrometry method for quantifying delamanid and its metabolite in small hair samples.
  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2020 Reckers A, Huo S, Esmail A, Dheda K, Bacchetti P, Gandhi M, Metcalfe J, Gerona R
• Brief Report: Understanding Preferences for HIV Care Among Patients Experiencing Homelessness or Unstable Housing: A Discrete Choice Experiment.
  Journal of acquired immune deficiency syndromes (1999) 2020 Conte M, Eshun-Wilson I, Geng E, Imbert E, Hickey MD, Havlir D, Gandhi M, Clemenzi-Allen A
• Viral suppression rates in a safety-net HIV clinic in San Francisco destabilized during COVID-19.
  AIDS (London, England) 2020 Spinelli MA, Hickey MD, Glidden DV, Nguyen JQ, Oskarsson JJ, Havlir D, Gandhi M
• PrEP Demonstration Project Showed Superior Adherence with Tenofovir Alafenamide/Emtricitabine Compared to Tenofovir Disoproxil Fumarate/Emtricitabine in a Sample of Partnered Sexual Minority Men.
  AIDS and behavior 2020 Robles G, Sauermilch D, Gandhi M, Starks TJ
• Facial Masking for Covid-19. Reply.
  The New England journal of medicine 2020 Gandhi M, Rutherford GW
• Evaluation of a novel community-based COVID-19 'Test-to-Care' model for low-income populations.
  PloS one 2020 Kerkhoff AD, Sachdev D, Mizany S, Rojas S, Gandhi M, Peng J, Black D, Jones D, Rojas S, Jacobo J, Tulier-Laiwa V, Petersen M, Martinez J, Chamie G, Havlir DV, Marquez C
• Point-of-care and Near Real-time Testing for Antiretroviral Adherence Monitoring to HIV Treatment and Prevention.
  Current HIV/AIDS reports 2020 Drain PK, Bardon AR, Simoni JM, Cressey TR, Anderson P, Sevenler D, Olanrewaju AO, Gandhi M, Celum C
• Social Support Mitigates Negative Impact of Food Insecurity on Antiretroviral Adherence Among Postpartum Women in Western Kenya.
  AIDS and behavior 2020 Wang M, Miller JD, Collins SM, Santoso MV, Wekesa P, Okochi H, Onono M, Weiser S, Gandhi M, Young SL
• A group-based mental health intervention for young people living with HIV in Tanzania: results of a pilot individually randomized group treatment trial.
  BMC public health 2020 Dow DE, Mmbaga BT, Gallis JA, Turner EL, Gandhi M, Cunningham CK, O'Donnell KE
• Approaches to Objectively Measure Antiretroviral Medication Adherence and Drive Adherence Interventions.
  Current HIV/AIDS reports 2020 Spinelli MA, Haberer JE, Chai PR, Castillo-Mancilla J, Anderson PL, Gandhi M
• The importance of PrEP persistence in preventing HIV infections on PrEP.
  Journal of the International AIDS Society 2020 Spinelli MA, Laborde N, Kinley P, Whitacre R, Scott HM, Walker N, Liu AY, Gandhi M, Buchbinder SP
• Masks Do More Than Protect Others During COVID-19: Reducing the Inoculum of SARS-CoV-2 to Protect the Wearer.
  Journal of general internal medicine 2020 Gandhi M, Beyrer C, Goosby E
• SARS-CoV-2 Community Transmission During Shelter-in-Place in San Francisco.
  medRxiv 2020 Gabriel Chamie, Carina Marquez, Emily Crawford, James Peng, Maya Petersen, Daniel Schwab, Joshua Schwab, Jackie Martinez, Diane Jones, Douglas Black, Monica Gandhi, Andrew D. Kerkhoff, Vivek Jain, …
• Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate.
  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2020 Cressey TR, Siriprakaisil O, Kubiak RW, Klinbuayaem V, Sukrakanchana PO, Quame-Amaglo J, Okochi H, Tawon Y, Cressey R, Baeten JM, Gandhi M, Drain PK
• Brief Report: High Accuracy of a Real-Time Urine Antibody-Based Tenofovir Point-of-Care Test Compared With Laboratory-Based ELISA in Diverse Populations.
  Journal of acquired immune deficiency syndromes (1999) 2020 Spinelli MA, Rodrigues WC, Wang G, Vincent M, Glidden DV, Okochi H, Stalter R, Defechereux P, Deutsch M, Grant RM, Ngure K, Mugo NR, Baeten JM, Gandhi M, Partners PrEP Study Team
• Improving Care Outcomes for PLWH Experiencing Homelessness and Unstable Housing: a Synthetic Review of Clinic-Based Strategies.
  Current HIV/AIDS reports 2020 Clemenzi-Allen AA, Hickey M, Conte M, Das D, Geng E, Riley E, Havlir D, Gandhi M, Imbert E
• Screening for Covid-19 in Skilled Nursing Facilities. Reply.
  The New England journal of medicine 2020 Gandhi M, Yokoe DS, Havlir DV
• Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples.
  Journal of Visualized Experiments 2020 Andrew Reckers, Anita Wen, David Aguilar, Peter Bacchetti, Monica Gandhi, John Metcalfe, Roy Gerona
• Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples.
  Journal of visualized experiments : JoVE 2020 Reckers A, Wen A, Aguilar D, Bacchetti P, Gandhi M, Metcalfe J, Gerona R
• Urine Tenofovir Concentrations Correlate With Plasma and Relate to Tenofovir Disoproxil Fumarate Adherence: A Randomized, Directly Observed Pharmacokinetic Trial (TARGET Study).
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020 Drain PK, Kubiak RW, Siriprakaisil O, Klinbuayaem V, Quame-Amaglo J, Sukrakanchana PO, Tanasri S, Punyati P, Sirirungsi W, Cressey R, Bacchetti P, Okochi H, Baeten JM, Gandhi M, Cressey TR
• A COVID-19 conference at AIDS 2020: Virtual.
  Lancet (London, England) 2020 Pozniak A, Bekker LG, Kamarulzaman A, Gandhi M, Horton R, Das P, Beyrer C
• Determinants of Viral Resuppression or Persistent Virologic Failure After Initial Failure With Second-Line Antiretroviral Treatment Among Asian Children and Adolescents With HIV.
  Journal of the Pediatric Infectious Diseases Society 2020 Teeraananchai S, Kerr SJ, Gandhi M, Do VC, Van Nguyen L, Tran DNH, Kosalaraksa P, Singtoroj T, Thammajaruk N, Jupimai T, Sohn AH
• Asymptomatic Transmission, the Achilles' Heel of Current Strategies to Control Covid-19.
  The New England journal of medicine 2020 Gandhi M, Yokoe DS, Havlir DV
• The Time for Universal Masking of the Public for Coronavirus Disease 2019 Is Now.
  Open forum infectious diseases 2020 Gandhi M, Havlir D
• Testing a Real-Time Tenofovir Urine Adherence Assay for Monitoring and Providing Feedback to Preexposure Prophylaxis in Kenya (PUMA): Protocol for a Pilot Randomized Controlled Trial.
  JMIR research protocols 2020 Drain P, Ngure K, Mugo N, Spinelli M, Chatterjee P, Bacchetti P, Glidden D, Baeten J, Gandhi M
• HIV preexposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine and changes in kidney function and tubular health.
  AIDS (London, England) 2020 Ascher SB, Scherzer R, Estrella MM, Shigenaga J, Spaulding KA, Glidden DV, Mehrotra ML, Defechereux P, Gandhi M, Grant RM, Shlipak MG, Jotwani V
• Missed opportunities to prevent HIV infections among pre-exposure prophylaxis users: a population-based mixed methods study, San Francisco, United States.
  Journal of the International AIDS Society 2020 Spinelli MA, Laborde N, Kinley P, Whitacre R, Scott HM, Walker N, Liu AY, Gandhi M, Buchbinder SP
• Correlation of Linezolid Hair Concentrations with Plasma Exposure in Patients with Drug-Resistant Tuberculosis.
  Antimicrobial agents and chemotherapy 2020 Wasserman S, Huo S, Ky K, Malig YN, Esmail A, Dheda K, Bacchetti P, Gerona R, Maartens G, Gandhi M, Metcalfe J
• Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study.
  The lancet. HIV 2020 Koss CA, Charlebois ED, Ayieko J, Kwarisiima D, Kabami J, Balzer LB, Atukunda M, Mwangwa F, Peng J, Mwinike Y, Owaraganise A, Chamie G, Jain V, Sang N, Olilo W, Brown LB, Marquez C, Zhang K, Ruel TD, …
• Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settings.
  AIDS (London, England) 2020 Gandhi M, Wang G, King R, Rodrigues WC, Vincent M, Glidden DV, Cressey TR, Bacchetti P, Spinelli MA, Okochi H, Siriprakaisil O, Klinbuayaem V, Mugo NR, Ngure K, Drain PK, Baeten JM
• Moving Antiretroviral Adherence Assessments to the Modern Era: Correlations Among Three Novel Measures of Adherence.
  AIDS and behavior 2020 Saberi P, Chakravarty D, Ming K, Legnitto D, Gandhi M, Johnson MO, Neilands TB
• The Golden Compass Program: Overview of the Initial Implementation of a Comprehensive Program for Older Adults Living with HIV.
  Journal of the International Association of Providers of AIDS Care 2020 Greene M, Myers J, Tan JY, Blat C, O'Hollaren A, Quintanilla F, Hsue P, Shiels M, Hicks ML, Olson B, Grochowski J, Oskarsson J, Havlir D, Gandhi M
• Using Real-Time Adherence Feedback to Enhance Communication About Adherence to Antiretroviral Therapy: Patient and Clinician Perspectives.
  The Journal of the Association of Nurses in AIDS Care : JANAC 2020 Hill LM, Golin CE, Pack A, Carda-Auten J, Wallace DD, Cherkur S, Farel CE, Rosen EP, Gandhi M, Asher Prince HM, Kashuba ADM
• Randomized controlled trial of a positive affect intervention to reduce HIV viral load among sexual minority men who use methamphetamine.
  Journal of the International AIDS Society 2019 Carrico AW, Neilands TB, Dilworth SE, Evans JL, G?mez W, Jain JP, Gandhi M, Shoptaw S, Horvath KJ, Coffin L, Discepola MV, Andrews R, Woods WJ, Feaster DJ, Moskowitz JT
• Racial/ethnic and HIV risk category disparities in preexposure prophylaxis discontinuation among patients in publicly funded primary care clinics.
  AIDS (London, England) 2019 Scott HM, Spinelli M, Vittinghoff E, Morehead-Gee A, Hirozawa A, James C, Hammer H, Liu A, Gandhi M, Buchbinder S
• Rectal Microbiome Alterations Associated With Oral Human Immunodeficiency Virus Pre-Exposure Prophylaxis.
  Open forum infectious diseases 2019 Fulcher JA, Li F, Cook RR, Zabih S, Louie A, Okochi H, Tobin NH, Gandhi M, Shoptaw S, Gorbach PM, Aldrovandi GM
• Short- and Long-Term Pharmacologic Measures of HIV Pre-exposure Prophylaxis Use Among High-Risk Men Who Have Sex With Men in HPTN 067/ADAPT.
  Journal of acquired immune deficiency syndromes (1999) 2019 Velloza J, Bacchetti P, Hendrix CW, Murnane P, Hughes JP, Li M, Curlin ME, Holtz TH, Mannheimer S, Marzinke MA, Amico KR, Liu A, Piwowar-Manning E, Eshleman SH, Dye BJ, Gandhi M, Grant RM, HPTN 067/…
• Low Rate of Sex-specific Analyses in Presentations at the Conference on Retroviruses and Opportunistic Infections (CROI) Meeting, 2018: Room to Improve.
  Journal of acquired immune deficiency syndromes (1999) 2019 Gandhi M, Smeaton LM, Vernon C, Scully EP, Gianella S, Poongulali S, Sheth AN, Van Schalkwyk M, Klingman KL, Short WR, Opollo VS, Cohn SE, Scarsi KK, Firnhaber C, Bares S, Swaminathan S, Mngqibisa R, …
• Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women.
  AIDS (London, England) 2019 Murnane PM, Bacchetti P, Currier JS, Brummel S, Okochi H, Phung N, Louie A, Kuncze K, Hoffman RM, Nematadzira T, Soko DK, Owor M, Saidi F, Flynn PM, Fowler MG, Gandhi M
• Simultaneous analysis of 11 medications for drug resistant TB in small hair samples to quantify adherence and exposure using a validated LC-MS/MS panel.
  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2019 Gerona R, Wen A, Aguilar D, Shum J, Reckers A, Bacchetti P, Gandhi M, Metcalfe J
• Motivational Interviewing to Reduce Drug Use and HIV Incidence Among Young Men Who Have Sex With Men in Relationships and Are High Priority for Pre-Exposure Prophylaxis (Project PARTNER): Randomized Controlled Trial Protocol.
  JMIR research protocols 2019 Starks TJ, Robles G, Pawson M, Jimenez RH, Gandhi M, Parsons JT, Millar BM
• Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration Project.
  AIDS research and human retroviruses 2019 Spinelli MA, Glidden DV, Anderson PL, Gandhi M, McMahan VM, Defechereux P, Schechter M, Veloso VG, Chariyalertsak S, Guanira JV, Bekker LG, Buchbinder SP, Grant RM
• Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing.
  Journal of acquired immune deficiency syndromes (1999) 2019 Spinelli MA, Glidden DV, Anderson PL, Gandhi M, Cohen S, Vittinghoff E, Coleman ME, Scott H, Bacon O, Elion R, Kolber MA, Buchbinder SP, Liu AY
• Increased Social Support Mitigates the Negative Impact of Food Insecurity on Antiretroviral Adherence Among Postpartum Women in Western Kenya (P04-126-19).
  Current Developments in Nutrition 2019 Mira Wang, Josh Miller, Shalean Collins, Marianne Santoso, Pauline Wekesa, Maricianah Onono, Monica Gandhi, Sera Young
• Measuring Adherence to Antiretroviral Therapy via Hair Concentrations in India.
  Journal of acquired immune deficiency syndromes (1999) 2019 Gandhi M, Devi S, Bacchetti P, Chandy S, Heylen E, Phung N, Kuncze K, Okochi H, Kumar R, Kurpad AV, Ekstrand ML
• Gendered dimensions of population mobility associated with HIV across three epidemics in rural Eastern Africa.
  Health & place 2019 Camlin CS, Akullian A, Neilands TB, Getahun M, Bershteyn A, Ssali S, Geng E, Gandhi M, Cohen CR, Maeri I, Eyul P, Petersen ML, Havlir DV, Kamya MR, Bukusi EA, Charlebois ED
• Willingness to Donate Hair Samples for Research Among People Living with HIV/AIDS Attending a Tertiary Health Facility in Ibadan, Nigeria.
  AIDS research and human retroviruses 2019 Nwogu JN, Babalola CP, Ngene SO, Taiwo BO, Berzins B, Gandhi M
• Acceptability and Feasibility of Self-Collecting Biological Specimens for HIV, Sexually Transmitted Infection, and Adherence Testing Among High-Risk Populations (Project Caboodle!): Protocol for an Exploratory Mixed-Methods Study.
  JMIR research protocols 2019 Sharma A, Stephenson R, Sallabank G, Merrill L, Sullivan S, Gandhi M
• Brief Report: Cocaine Use and Pre-exposure Prophylaxis: Adherence, Care Engagement, and Kidney Function.
  Journal of acquired immune deficiency syndromes (1999) 2019 Hojilla JC, Satre DD, Glidden DV, McMahan VM, Gandhi M, Defechereux P, Guanira JV, Mehrotra M, Grant RM, Carrico AW
• Brief Report: Validation of a Urine Tenofovir Immunoassay for Adherence Monitoring to PrEP and ART and Establishing the Cutoff for a Point-of-Care Test.
  Journal of acquired immune deficiency syndromes (1999) 2019 Gandhi M, Bacchetti P, Spinelli MA, Okochi H, Baeten JM, Siriprakaisil O, Klinbuayaem V, Rodrigues WC, Wang G, Vincent M, Cressey TR, Drain PK
• Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB.
  ERJ open research 2019 Metcalfe J, Bacchetti P, Gerona R, Esmail A, Dheda K, Gandhi M
• Addressing the Sexually Transmitted Infection and HIV Syndemic.
  JAMA 2019 Gandhi M, Spinelli MA, Mayer KH
• Low tenofovir level in urine by a novel immunoassay is associated with seroconversion in a preexposure prophylaxis demonstration project.
  AIDS (London, England) 2019 Spinelli MA, Glidden DV, Rodrigues WC, Wang G, Vincent M, Okochi H, Kuncze K, Mehrotra M, Defechereux P, Buchbinder SP, Grant RM, Gandhi M
• RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population.
  AIDS (London, England) 2019 Coffey S, Bacchetti P, Sachdev D, Bacon O, Jones D, Ospina-Norvell C, Torres S, Lynch E, Camp C, Mercer-Slomoff R, Lee S, Christopoulos K, Pilcher C, Hsu L, Jin C, Scheer S, Havlir D, Gandhi M
• Housing Instability Results in Increased Acute Care Utilization in an Urban HIV Clinic Cohort.
  Open forum infectious diseases 2019 Clemenzi-Allen A, Neuhaus J, Geng E, Sachdev D, Buchbinder S, Havlir D, Gandhi M, Christopoulos K
• Sex-Based Differences in Human Immunodeficiency Virus Type 1 Reservoir Activity and Residual Immune Activation.
  The Journal of infectious diseases 2019 Scully EP, Gandhi M, Johnston R, Hoh R, Lockhart A, Dobrowolski C, Pagliuzza A, Milush JM, Baker CA, Girling V, Ellefson A, Gorelick R, Lifson J, Altfeld M, Alter G, Cedars M, Solomon A, Lewin SR, …
• Antiretroviral Concentrations in Hair Strongly Predict Virologic Response in a Large Human Immunodeficiency Virus Treatment-naive Clinical Trial.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019 Gandhi M, Bacchetti P, Ofokotun I, Jin C, Ribaudo HJ, Haas DW, Sheth AN, Horng H, Phung N, Kuncze K, Okochi H, Landovitz RJ, Lennox J, Currier JS, AIDS Clinical Trials Group (ACTG) 5257 Study Team
• Evaluating the Impact of Housing Status on Gonorrhea and Chlamydia Screening in an HIV Primary Care Setting.
  Sexually transmitted diseases 2019 Clemenzi-Allen AA, Hartogensis W, Cohen SE, Gandhi M, Geng E, Christopoulos K
• Missed Visits Associated With Future Preexposure Prophylaxis (PrEP) Discontinuation Among PrEP Users in a Municipal Primary Care Health Network.
  Open forum infectious diseases 2019 Spinelli MA, Scott HM, Vittinghoff E, Liu AY, Gonzalez R, Morehead-Gee A, Gandhi M, Buchbinder SP
• Feasibility and acceptability of novel methods to estimate antiretroviral adherence: A longitudinal study.
  PloS one 2019 Saberi P, Ming K, Legnitto D, Neilands TB, Gandhi M, Johnson MO
• Patient and clinician perspectives on optimizing graphical displays of longitudinal medication adherence data.
  Patient education and counseling 2019 Pack AP, Golin CE, Hill LM, Carda-Auten J, Wallace DD, Cherkur S, Farel CE, Rosen EP, Gandhi M, Asher Prince HM, Kashuba ADM
• Mentoring the Mentors: Implementation and Evaluation of Four Fogarty-Sponsored Mentoring Training Workshops in Low-and Middle-Income Countries.
  The American journal of tropical medicine and hygiene 2019 Gandhi M, Raj T, Fernandez R, Rispel L, Nxumalo N, Lescano AG, Bukusi EA, Mmbaga BT, Heimburger DC, Cohen CR
• Patient and provider perceptions of a comprehensive care program for HIV-positive adults over 50 years of age: The formation of the Golden Compass HIV and aging care program in San Francisco.
  PloS one 2018 Greene ML, Tan JY, Weiser SD, Christopoulos K, Shiels M, O'Hollaren A, Mureithi E, Meissner L, Havlir D, Gandhi M
• Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report.
  The lancet. HIV 2018 Cohen SE, Sachdev D, Lee SA, Scheer S, Bacon O, Chen MJ, Okochi H, Anderson PL, Kearney MF, Coffey S, Scott H, Grant RM, Havlir D, Gandhi M
• 1298. Acquisition of TDF-Susceptible HIV Despite High Level Adherence to Daily TDF/FTC PrEP as Measured by Dried Blood Spot (DBS) and Segmental Hair Analysis: A Case Report.
  Open Forum Infectious Diseases 2018 Stephanie E Cohen, Darpun Sachdev, Sulggi Lee, Susan Scheer, Oliver Bacon, Miao-Jung Chen, Clarissa Ospina Norvell, Hideaki Okochi, Peter Anderson, Susa Coffey, Hyman Scott, Diane Havlir, Monica …
• 2272. High Interest in Doxycycline for Sexually Transmitted Infection Post-Exposure Prophylaxis (Doxy-PEP) in a Multi-city Survey of Men Having Sex With Men (MSM) Using a Social-Networking App.
  Open Forum Infectious Diseases 2018 Matthew A Spinelli, Hyman Scott, Eric Vittinghoff, Albert Y Liu, Kenneth Coleman, Monica Gandhi, Susan P Buchbinder
• Brief Report: A Panel Management and Patient Navigation Intervention Is Associated With Earlier PrEP Initiation in a Safety-Net Primary Care Health System.
  Journal of acquired immune deficiency syndromes (1999) 2018 Spinelli MA, Scott HM, Vittinghoff E, Liu AY, Morehead-Gee A, Gonzalez R, Gandhi M, Buchbinder SP
• Similar tenofovir hair concentrations in men and women after directly observed dosing of tenofovir disoproxil fumarate/emtricitabine: implications for preexposure prophylaxis adherence monitoring.
  AIDS (London, England) 2018 Koss CA, Liu AY, Castillo-Mancilla J, Bacchetti P, McHugh C, Kuncze K, Morrow M, Louie A, Seifert S, Okochi H, MaWhinney S, Gandhi M, Anderson PL
• Acquisition of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Infection in a Patient Taking Preexposure Prophylaxis.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2018 Colby DJ, Kroon E, Sacdalan C, Gandhi M, Grant RM, Phanuphak P, Ananworanich J, Robb ML, Phanuphak N
• Development and Validation of an Immunoassay for Tenofovir in Urine as a Real-Time Metric of Antiretroviral Adherence.
  EClinicalMedicine 2018 Gandhi M, Bacchetti P, Rodrigues WC, Spinelli M, Koss CA, Drain PK, Baeten JM, Mugo NR, Ngure K, Benet LZ, Okochi H, Wang G, Vincent M
• Estrogen receptor-1 is a key regulator of HIV-1 latency that imparts gender-specific restrictions on the latent reservoir.
  Proceedings of the National Academy of Sciences of the United States of America 2018 Das B, Dobrowolski C, Luttge B, Valadkhan S, Chomont N, Johnston R, Bacchetti P, Hoh R, Gandhi M, Deeks SG, Scully E, Karn J
• Population mobility associated with higher risk sexual behaviour in eastern African communities participating in a Universal Testing and Treatment trial.
  Journal of the International AIDS Society 2018 Camlin CS, Akullian A, Neilands TB, Getahun M, Eyul P, Maeri I, Ssali S, Geng E, Gandhi M, Cohen CR, Kamya MR, Odeny T, Bukusi EA, Charlebois ED
• Cumulative Antiretroviral Exposure Measured in Hair Is Not Associated With Measures of HIV Persistence or Inflammation Among Individuals on Suppressive ART.
  The Journal of infectious diseases 2018 Gandhi M, Gandhi RT, Stefanescu A, Bosch RJ, Cyktor JC, Horng H, Louie A, Phung N, Eron JJ, Hogg E, Macatangay BJC, Hensel C, Fletcher CV, Mellors JW, McMahon DK, A5321 Team
• Novel methods to estimate antiretroviral adherence: protocol for a longitudinal study.
  Patient preference and adherence 2018 Saberi P, Ming K, Legnitto D, Neilands TB, Gandhi M, Johnson MO
• Antiretroviral drug concentrations in hair are associated with virologic outcomes among young people living with HIV in Tanzania.
  AIDS (London, England) 2018 Tabb ZJ, Mmbaga BT, Gandhi M, Louie A, Kuncze K, Okochi H, Shayo AM, Turner EL, Cunningham CK, Dow DE
• Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals.
  Journal of acquired immune deficiency syndromes (1999) 2018 Jotwani V, Scherzer R, Glidden DV, Mehrotra M, Defechereux P, Liu A, Gandhi M, Bennett M, Coca SG, Parikh CR, Grant RM, Shlipak MG
• Seroconversion on preexposure prophylaxis: a case report with segmental hair analysis for timed adherence determination.
  AIDS (London, England) 2018 Thaden JT, Gandhi M, Okochi H, Hurt CB, McKellar MS
• Loneliness in Older Adults Living with HIV.
  AIDS and behavior 2018 Greene M, Hessol NA, Perissinotto C, Zepf R, Hutton Parrott A, Foreman C, Whirry R, Gandhi M, John M
• Utility of Different Adherence Measures for PrEP: Patterns and Incremental Value.
  AIDS and behavior 2018 Abaasa A, Hendrix C, Gandhi M, Anderson P, Kamali A, Kibengo F, Sanders EJ, Mutua G, Bumpus NN, Priddy F, Haberer JE
• Development and validation of an assay to analyze atazanavir in human hair via liquid chromatography/tandem mass spectrometry.
  Rapid communications in mass spectrometry : RCM 2018 Phung N, Kuncze K, Okochi H, Louie A, Benet LZ, Ofokotun I, Haas DW, Currier JS, Chawana TD, Sheth AN, Bacchetti P, Gandhi M, Horng H
• Degree of Housing Instability Shows Independent "Dose-Response" With Virologic Suppression Rates Among People Living With Human Immunodeficiency Virus.
  Open forum infectious diseases 2018 Clemenzi-Allen A, Geng E, Christopoulos K, Hammer H, Buchbinder S, Havlir D, Gandhi M
• Brief Report: Adherence Biomarker Measurements in Older and Younger HIV-Infected Adults Receiving Tenofovir-Based Therapy.
  Journal of acquired immune deficiency syndromes (1999) 2018 Seifert SM, Castillo-Mancilla JR, Erlandson K, Morrow M, Gandhi M, Kuncze K, Horng H, Zheng JH, Bushman LR, Kiser JJ, MaWhinney S, Anderson PL
• Ready-made and custom-made eyeglasses in India: a cost-effectiveness analysis of a randomised controlled trial.
  BMJ open ophthalmology 2018 Angell B, Ali F, Gandhi M, Mathur U, Friedman DS, Jan S, Keay L
• A Simple Pre-Exposure Prophylaxis (PrEP) Optimization Intervention for Health Care Providers Prescribing PrEP: Pilot Study.
  JMIR formative research 2018 Saberi P, Berrean B, Thomas S, Gandhi M, Scott H
• Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial.
  PloS one 2018 Baxi SM, Vittinghoff E, Bacchetti P, Huang Y, Chillag K, Wiegand R, Anderson PL, Grant R, Greenblatt RM, Buchbinder S, Gandhi M, Liu AY
• Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2018 Koss CA, Hosek SG, Bacchetti P, Anderson PL, Liu AY, Horng H, Benet LZ, Kuncze K, Louie A, Saberi P, Wilson CM, Gandhi M
• Human Immunodeficiency Virus in Women. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
  Human Immunodeficiency Virus in Women. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 2018 Cohn SE, Chappell C, Gandhi M.
• Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis.
  PloS one 2017 Mave V, Kinikar A, Kagal A, Nimkar S, Koli H, Khwaja S, Bharadwaj R, Gerona R, Wen A, Ramachandran G, Kumar H, Bacchetti P, Dooley KE, Gupte N, Gupta A, Gandhi M
• Brief Report: Lopinavir Hair Concentrations Are the Strongest Predictor of Viremia in HIV-Infected Asian Children and Adolescents on Second-Line Antiretroviral Therapy.
  Journal of acquired immune deficiency syndromes (1999) 2017 Pintye J, Bacchetti P, Teeraananchai S, Kerr S, Prasitsuebsai W, Singtoroj T, Kuncze K, Louie A, Koss CA, Jin C, Phung N, Horng H, Sohn AH, Gandhi M
• Newly Acquired Infection With Multidrug-Resistant HIV-1 in a Patient Adherent to Preexposure Prophylaxis.
  Journal of acquired immune deficiency syndromes (1999) 2017 Markowitz M, Grossman H, Anderson PL, Grant R, Gandhi M, Horng H, Mohri H
• Strong Correlation Between Concentrations of Antiretrovirals in Home-Collected and Study-Collected Hair Samples: Implications for Adherence Monitoring.
  Journal of acquired immune deficiency syndromes (1999) 2017 Saberi P, Neilands TB, Ming K, Johnson MO, Kuncze K, Koss CA, Gandhi M
• A Pharmacist-Led Program to Evaluate and Reduce Polypharmacy and Potentially Inappropriate Prescribing in Older HIV-Positive Patients.
  Pharmacotherapy 2017 McNicholl IR, Gandhi M, Hare CB, Greene M, Pierluissi E
• Individual and partnership factors associated with anticipated versus actual partner notification following STI diagnosis among men who have sex with men and/or with transgender women in Lima, Peru.
  Sexually transmitted infections 2017 Braun HM, Segura ER, Lake JE, Gandhi M, Rios J, Villaran MV, Sanchez J, Lama JR, Clark JL
• Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomen.
  AIDS (London, England) 2017 Gandhi M, Murnane PM, Bacchetti P, Elion R, Kolber MA, Cohen SE, Horng H, Louie A, Kuncze K, Koss CA, Anderson PL, Buchbinder S, Liu A
• An LC-MS/MS-based method to analyze the anti-tuberculosis drug bedaquiline in hair.
  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2017 Metcalfe J, Gerona R, Wen A, Bacchetti P, Gandhi M
• Defining a Cutoff for Atazanavir in Hair Samples Associated With Virological Failure Among Adolescents Failing Second-Line Antiretroviral Treatment.
  Journal of acquired immune deficiency syndromes (1999) 2017 Chawana TD, Gandhi M, Nathoo K, Ngara B, Louie A, Horng H, Katzenstein D, Metcalfe J, Nhachi CFB, Adolescent Treatment Failure (ATF) study team
• Newly Acquired Infection with Multi-Drug Resistant HIV-1 in a Patient Adherent to Pre-Exposure Prophylaxis.
  Journal of acquired immune deficiency syndromes (1999) 2017 Markowitz M, Grossman H, Anderson PL, Grant R, Gandhi M, Horng H, Mohri H
• Predicting death over 8 years in a prospective cohort of HIV-infected women: the Women's Interagency HIV Study.
  BMJ open 2017 Gustafson DR, Shi Q, Holman S, Minkoff H, Cohen MH, Plankey MW, Havlik R, Sharma A, Gange S, Gandhi M, Milam J, Hoover DR
• Using the multiphase optimization strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol.
  BMC public health 2017 Gwadz MV, Collins LM, Cleland CM, Leonard NR, Wilton L, Gandhi M, Scott Braithwaite R, Perlman DC, Kutnick A, Ritchie AS
• Limitations of using the Lorenz curve framework to understand the distribution of population viral load: authors' reply.
  AIDS (London, England) 2017 Christopoulos KA, Hartogensis W, Glidden DV, Pilcher CD, Gandhi M, Geng EH
• Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations.
  AIDS research and human retroviruses 2017 Koss CA, Bacchetti P, Hillier SL, Livant E, Horng H, Mgodi N, Mirembe BG, Gomez Feliciano K, Horn S, Liu AY, Glidden DV, Grant RM, Benet LZ, Louie A, van der Straten A, Chirenje ZM, Marrazzo JM, …
• The Lorenz curve: a novel method for understanding viral load distribution at the population level.
  AIDS (London, England) 2017 Christopoulos KA, Hartogensis W, Glidden DV, Pilcher CD, Gandhi M, Geng EH
• Association of Self-Reported Adherence and Antiretroviral Drug Concentrations in Hair Among Youth with Virologic Failure in Tanzania.
  Open Forum Infectious Diseases 2017 Zachary Tabb, Blandina Mmbaga, Monica Gandhi, Alexander Louie, Karen Kuncze, Aisa Shayo, Elizabeth Turner, Coleen Cunningham, Dorothy Dow
• The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting.
  Journal of acquired immune deficiency syndromes (1999) 2017 Pilcher CD, Ospina-Norvell C, Dasgupta A, Jones D, Hartogensis W, Torres S, Calderon F, Demicco E, Geng E, Gandhi M, Havlir DV, Hatano H
• Women's Empowerment and Global Health: A Twenty-First-Century Agenda
  Women's Empowerment and Global Health: A Twenty-First-Century Agenda 2016 Shari L. Dworkin, Monica Gandhi, Paige Passano
• Creating More Effective Mentors: Mentoring the Mentor.
  AIDS and behavior 2016 Gandhi M, Johnson M
• Geriatric Assessments and Association With VACS Index Among HIV-Infected Older Adults in San Francisco.
  Journal of acquired immune deficiency syndromes (1999) 2016 John MD, Greene M, Hessol NA, Zepf R, Parrott AH, Foreman C, Bourgeois J, Gandhi M, Hare CB
• A multi-analyte panel for non-invasive pharmacokinetic monitoring of second-line anti-tuberculosis drugs.
  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2016 Gerona R, Wen A, Koss C, Bacchetti P, Gandhi M, Metcalfe J
• HIV pre-exposure prophylaxis for women.
  Journal of virus eradication 2016 Sheth AN, Rolle CP, Gandhi M
• "The Pleasure Is Better as I've Gotten Older": Sexual Health, Sexuality, and Sexual Risk Behaviors Among Older Women Living With HIV.
  Archives of sexual behavior 2016 Taylor TN, Munoz-Plaza CE, Goparaju L, Martinez O, Holman S, Minkoff HL, Karpiak SE, Gandhi M, Cohen MH, Golub ET, Levine AM, Adedimeji AA, Gonsalves R, Bryan T, Connors N, Schechter G, Wilson TE
• Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis.
  PloS one 2016 Gerona R, Wen A, Chin AT, Koss CA, Bacchetti P, Metcalfe J, Gandhi M
• Movement between facilities for HIV care among a mobile population in Kenya: transfer, loss to follow-up, and reengagement.
  AIDS care 2016 Hickey MD, Omollo D, Salmen CR, Mattah B, Blat C, Ouma GB, Fiorella KJ, Njoroge B, Gandhi M, Bukusi EA, Cohen CR, Geng EH
• A qualitative assessment of barriers and facilitators to antiretroviral adherence in Thai patients.
  Journal of virus eradication 2016 Phuphanich M, Rattanamahattana M, Avihingsanon A, Chetchotisakd P, Putcharoen O, Gandhi M, Sohn AH, Imrie J, Phanuphak P, Kerr SJ
• B-107 Distinct mechanisms of hormonal control of HIV latency in T-cells and microglial cells.
  JAIDS Journal of Acquired Immune Deficiency Syndromes 2016 Jonathan Karn, Biswajit Das, Curtis Dobrowolski, Yoelvis Garcia-Mesa, David Alvarez-Carbonell, Stephanie Milne, Eileen Scully, Steven Deeks, Monica Gandhi, Rowena Johnston
• "Wan Kanyakla" (We are together): Community transformations in Kenya following a social network intervention for HIV care.
  Social science & medicine (1982) 2015 Salmen CR, Hickey MD, Fiorella KJ, Omollo D, Ouma G, Zoughbie D, Salmen MR, Magerenge R, Tessler R, Campbell H, Geng E, Gandhi M, Bukusi EA, Cohen CR
• Estrogen potently blocks HIV re-emergence from latency and points to gender-specific differences in HIV reservoirs and novel cure strategies.
  Journal of Virus Eradication 2015 J. Karn, B. Das, C. Dobrowolski, E. Scully, S.G. Deeks, M. Gandhi, R.E. Johnston
• Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study.
  The lancet. HIV 2015 Patel RC, Onono M, Gandhi M, Blat C, Hagey J, Shade SB, Vittinghoff E, Bukusi EA, Newmann SJ, Cohen CR
• Behavioral intervention improves treatment outcomes among HIV-infected individuals who have delayed, declined, or discontinued antiretroviral therapy: a randomized controlled trial of a novel intervention.
  AIDS and behavior 2015 Gwadz M, Cleland CM, Applegate E, Belkin M, Gandhi M, Salomon N, Banfield A, Leonard N, Riedel M, Wolfe H, Pickens I, Bolger K, Bowens D, Perlman D, Mildvan D, Heart to Heart Collaborative Research …
• Using Lopinavir Concentrations in Hair Samples to Assess Treatment Outcomes on Second-Line Regimens Among Asian Children.
  AIDS research and human retroviruses 2015 Prasitsuebsai W, Kerr SJ, Truong KH, Ananworanich J, Do VC, Nguyen LV, Kurniati N, Kosalaraksa P, Sudjaritruk T, Chokephaibulkit K, Thammajaruk N, Singtoroj T, Teeraananchai S, Horng H, Bacchetti P, …
• Implementation and Operational Research: Pulling the Network Together: Quasiexperimental Trial of a Patient-Defined Support Network Intervention for Promoting Engagement in HIV Care and Medication Adherence on Mfangano Island, Kenya.
  Journal of acquired immune deficiency syndromes (1999) 2015 Hickey MD, Salmen CR, Omollo D, Mattah B, Fiorella KJ, Geng EH, Bacchetti P, Blat C, Ouma GB, Zoughbie D, Tessler RA, Salmen MR, Campbell H, Gandhi M, Shade S, Njoroge B, Bukusi EA, Cohen CR
• HIV Prevention among Women: Current and Future Challenges. HIV Specialist
  HIV Prevention among Women: Current and Future Challenges. HIV Specialist. 2015 Sheth A and Gandhi M. July 2015
• Implementation challenges for long-acting antivirals as treatment.
  Current opinion in HIV and AIDS 2015 Havlir D, Gandhi M
• Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected Patients.
  PloS one 2015 Baxi SM, Greenblatt RM, Bacchetti P, Jin C, French AL, Keller MJ, Augenbraun MH, Gange SJ, Liu C, Mack WJ, Gandhi M, Women’s Interagency HIV Study (WIHS)
• Longitudinal Trends in Sexual Behaviors with Advancing Age and Menopause Among Women With and Without HIV-1 Infection.
  AIDS and behavior 2015 Taylor TN, Weedon J, Golub ET, Karpiak SE, Gandhi M, Cohen MH, Levine AM, Minkoff HL, Adedimeji AA, Goparaju L, Holman S, Wilson TE
• Hair concentrations of antiretrovirals predict viral suppression in HIV-infected pregnant and breastfeeding Ugandan women.
  AIDS (London, England) 2015 Koss CA, Natureeba P, Mwesigwa J, Cohan D, Nzarubara B, Bacchetti P, Horng H, Clark TD, Plenty A, Ruel TD, Achan J, Charlebois ED, Kamya MR, Havlir DV, Gandhi M
• Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence Monitoring.
  The Journal of infectious diseases 2015 Gandhi M, Glidden DV, Liu A, Anderson PL, Horng H, Defechereux P, Guanira JV, Grinsztejn B, Chariyalertsak S, Bekker LG, Grant RM, iPrEx Study Team
• Increase of perceived frequency of neighborhood domestic violence is associated with increase of women's depression symptoms in a nationally representative longitudinal study in South Africa.
  Social science & medicine (1982) 2015 Meffert SM, McCulloch CE, Neylan TC, Gandhi M, Lund C
• Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women.
  AIDS (London, England) 2015 Cohan D, Natureeba P, Koss CA, Plenty A, Luwedde F, Mwesigwa J, Ades V, Charlebois ED, Gandhi M, Clark TD, Nzarubara B, Achan J, Ruel T, Kamya MR, Havlir DV
• Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measures.
  Journal of acquired immune deficiency syndromes (1999) 2015 Baxi SM, Liu A, Bacchetti P, Mutua G, Sanders EJ, Kibengo FM, Haberer JE, Rooney J, Hendrix CW, Anderson PL, Huang Y, Priddy F, Gandhi M
• Human papillomavirus knowledge, vaccine acceptance, and vaccine series completion among female entertainment and sex workers in Phnom Penh, Cambodia: the Young Women's Health Study.
  International journal of STD & AIDS 2014 Wadhera P, Evans JL, Stein E, Gandhi M, Couture MC, Sansothy N, Sichan K, Maher L, Kaldor J, Page K, YWHS Collaborative
• Assessment of HIV antiretroviral therapy adherence by measuring drug concentrations in hair among children in rural Uganda.
  AIDS care 2014 Olds PK, Kiwanuka JP, Nansera D, Huang Y, Bacchetti P, Jin C, Gandhi M, Haberer JE
• Single-pill regimens for HIV-1 infection.
  The New England journal of medicine 2014 Gandhi M, Gandhi RT
• A mentor training program improves mentoring competency for researchers working with early-career investigators from underrepresented backgrounds.
  Advances in health sciences education : theory and practice 2014 Johnson MO, Gandhi M
• Antiretroviral concentrations in small hair samples as a feasible marker of adherence in rural Kenya.
  Journal of acquired immune deficiency syndromes (1999) 2014 Hickey MD, Salmen CR, Tessler RA, Omollo D, Bacchetti P, Magerenge R, Mattah B, Salmen MR, Zoughbie D, Fiorella KJ, Geng E, Njoroge B, Jin C, Huang Y, Bukusi EA, Cohen CR, Gandhi M
• A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans.
  AIDS (London, England) 2014 Scherzer R, Gandhi M, Estrella MM, Tien PC, Deeks SG, Grunfeld C, Peralta CA, Shlipak MG
• Development and implementation of a workshop to enhance the effectiveness of mentors working with diverse mentees in HIV research.
  AIDS research and human retroviruses 2014 Gandhi M, Fernandez A, Stoff DM, Narahari S, Blank M, Fuchs J, Evans CH, Kahn JS, Johnson MO
• Smoking cessation and recidivism in the Women's Interagency Human Immunodeficiency Virus Study.
  American journal of preventive medicine 2014 Hessol NA, Weber KM, D'Souza G, Burton D, Young M, Milam J, Murchison L, Gandhi M, Cohen MH
• Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP).
  PloS one 2014 Liu AY, Yang Q, Huang Y, Bacchetti P, Anderson PL, Jin C, Goggin K, Stojanovski K, Grant R, Buchbinder SP, Greenblatt RM, Gandhi M
• Common clinical conditions - age, low BMI, ritonavir use, mild renal impairment - affect tenofovir pharmacokinetics in a large cohort of HIV-infected women.
  AIDS (London, England) 2014 Baxi SM, Greenblatt RM, Bacchetti P, Scherzer R, Minkoff H, Huang Y, Anastos K, Cohen M, Gange SJ, Young M, Shlipak MG, Gandhi M
• 1607Veterans Aging Cohort Study (VACS) Index, Functional Status, and Other Patient Reported Outcomes in Older HIV-positive (HIV+) Adults.
  Open Forum Infectious Diseases 2014 Malcolm John, Nancy Hessol, C. Bradley Hare, Catherine Lyons, Roland Zepf, Terrence Marcotte, Amanda Hutton Parrott, Robert Whirry, Cameron Foreman, Monica Gandhi, Meredith Greene
• Short communication: A low-cost method for analyzing nevirapine levels in hair as a marker of adherence in resource-limited settings.
  AIDS research and human retroviruses 2013 Gandhi M, Yang Q, Bacchetti P, Huang Y
• Understanding the disparity: predictors of virologic failure in women using highly active antiretroviral therapy vary by race and/or ethnicity.
  Journal of acquired immune deficiency syndromes (1999) 2013 McFall AM, Dowdy DW, Zelaya CE, Murphy K, Wilson TE, Young MA, Gandhi M, Cohen MH, Golub ET, Althoff KN, Women's Interagency HIV Study
• Association of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United States.
  AIDS (London, England) 2013 Murphy K, Hoover DR, Shi Q, Cohen M, Gandhi M, Golub ET, Gustafson DR, Pearce CL, Young M, Anastos K
• Pharmacokinetics of lopinavir/ritonavir and efavirenz in food insecure HIV-infected pregnant and breastfeeding women in Tororo, Uganda.
  Journal of clinical pharmacology 2013 Bartelink IH, Savic RM, Mwesigwa J, Achan J, Clark T, Plenty A, Charlebois E, Kamya M, Young SL, Gandhi M, Havlir D, Cohan D, Aweeka F
• Common Clinical Conditions - Age, Low BMI, Ritonavir Use, Mild Renal Impairment - Affect Tenofovir Pharmacokinetics in a Large Cohort of HIV-Infected Women. AIDS (in press)
  Common Clinical Conditions - Age, Low BMI, Ritonavir Use, Mild Renal Impairment - Affect Tenofovir Pharmacokinetics in a Large Cohort of HIV-Infected Women. AIDS (in press) 2013 Baxi SM, Greenblatt RM, Bacchetti P, Schwerzer R, Minkoff H, Huang Y, Anastos K, Cohen M, Gange SJ, Young M, Shlipak MS, Gandhi M
• Hair and Plasma Data Show that Lopinavir, Ritonavir and Efavirenz All Transfer from Mother to Infant in Utero, but only Efavirenz Transfers via Breastfeeding. JAIDS Aug 63(5): 578-584
  Hair and Plasma Data Show that Lopinavir, Ritonavir and Efavirenz All Transfer from Mother to Infant in Utero, but only Efavirenz Transfers via Breastfeeding. JAIDS Aug 63(5): 578-584. 2013 Gandhi M, Mwesigwa J, Aweeka F, Plenty A, Charlebois E, Ruel TD, Huang Y, Clark T, Ades V, Natureeba P, Luwedde FA, Achan J, Kamya MR, Havlir DV, Cohan D
• Pharmacokinetics of lopinavir/ritonavir and efavirenz in malnourished HIV-infected pregnant and breastfeeding women in Tororo, Uganda. Journal of Clinical Pharmacology (in press)
  Pharmacokinetics of lopinavir/ritonavir and efavirenz in malnourished HIV-infected pregnant and breastfeeding women in Tororo, Uganda. Journal of Clinical Pharmacology (in press) 2013 Bartelink IH, Savic R, Mwesigwa J, Achan J, Clark T, Plenty A, Charlebois E, Kamya M, Young SL, Gandhi M, Havlir D, Cohan D, Aweeka F
• Hair and plasma data show that lopinavir, ritonavir, and efavirenz all transfer from mother to infant in utero, but only efavirenz transfers via breastfeeding.
  Journal of acquired immune deficiency syndromes (1999) 2013 Gandhi M, Mwesigwa J, Aweeka F, Plenty A, Charlebois E, Ruel TD, Huang Y, Clark T, Ades V, Natureeba P, Luwedde FA, Achan J, Kamya MR, Havlir DV, Cohan D, Prevention of Malaria and HIV disease in …
• Targeting imported malaria through social networks: a potential strategy for malaria elimination in Swaziland.
  Malaria journal 2013 Koita K, Novotny J, Kunene S, Zulu Z, Ntshalintshali N, Gandhi M, Gosling R
• Tenofovir use and urinary biomarkers among HIV-infected women in the Women's Interagency HIV Study (WIHS).
  Journal of acquired immune deficiency syndromes (1999) 2013 Oboho I, Abraham AG, Benning L, Anastos K, Sharma A, Young M, Burian P, Gandhi M, Cohen M, Szczech L
• Acute pancreas allograft rejection is associated with increased risk of graft failure in pancreas transplantation.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2013 Dong M, Parsaik AK, Kremers W, Sun A, Dean P, Prieto M, Cosio FG, Gandhi MJ, Zhang L, Smyrk TC, Stegall MD, Kudva YC
• An Incidental Abscess in a Patient with Acquired Immunodeficiency Syndrome.
  Infectious diseases in clinical practice (Baltimore, Md.) 2012 Baxi SM, Gandhi M
• Infectious Diseases in Clinical Practice
  An Incidental Abscess in a Patient with Acquired Immunodeficiency Syndrome 2012 Baxi S and Gandhi M
• Track B Clinical Science.
  Journal of the International AIDS Society 2012 . Kyrychenko, G. Dubynska, T. Koval, I. Kaidashev, V. Korshenko, K. Rono, H. Kibuuka, L. Maganga, J. Kosgei, A. Sekiziyivu, E. Sanga, E. Ngetich, A. Bolen Valenzuela, N. Michael, M. Robb, M. Markowitz…
• The effect of a "universal antiretroviral therapy" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/μL in a public health setting.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012 Geng EH, Hare CB, Kahn JO, Jain V, Van Nunnery T, Christopoulos KA, Deeks SG, Gandhi M, Havlir DV
• A single-nucleotide polymorphism in CYP2B6 leads to >3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected women.
  The Journal of infectious diseases 2012 Gandhi M, Greenblatt RM, Bacchetti P, Jin C, Huang Y, Anastos K, Cohen M, Dehovitz JA, Sharp GB, Gange SJ, Liu C, Hanson SC, Aouizerat B, Women's Interagency HIV Study
• Visual function after correction of distance refractive error with ready-made and custom spectacles: a randomized clinical trial.
  Ophthalmology 2012 Brady CJ, Villanti AC, Gandhi M, Friedman DS, Keay L
• An investigation of the possible interaction between the use of Vitamin C and highly active antiretroviral therapy (HAART) adherence and effectiveness in treated HIV+ women.
  Complementary therapies in medicine 2012 Merenstein D, Wang C, Gandhi M, Robison E, Levine AM, Schwartz RM, Weber KM, Liu C
• Chapter 39 Special issues regarding women with HIV infection.
  Sande\u0027s HIV/AIDS Medicine 2012 Ruth M. Greenblatt, Monica Gandhi
• Chapter 42. Special Issues Regarding Women with HIV Infection. In Sande’s HIV/AIDS Medicine: Medical Management of AIDS. Volberding P, Greene WC, Lange JMA, Sewankambo NK, Gallant JE (Eds)
  Chapter 42. Special Issues Regarding Women with HIV Infection. In Sande’s HIV/AIDS Medicine: Medical Management of AIDS. Volberding P, Greene WC, Lange JMA, Sewankambo NK, Gallant JE (Eds). 2012 Greenblatt RM and Gandhi M.
• Short-term garlic supplementation and highly active antiretroviral treatment adherence, CD4+ cell counts, and human immunodeficiency virus viral load.
  Alternative therapies in health and medicine 2012 Liu C, Wang C, Robison E, Levine AM, Gandhi M, Schwartz R, Weber KM, Merenstein D
• The effect of AIDS Clinical Trials Group Protocol 5164 on the time from Pneumocystis jirovecii pneumonia diagnosis to antiretroviral initiation in routine clinical practice: a case study of diffusion, dissemination, and implementation.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011 Geng EH, Kahn JS, Chang OC, Hare CB, Christopoulos KA, Jones D, Petersen ML, Deeks SG, Havlir DV, Gandhi M
• Microanalysis of the antiretroviral nevirapine in human hair from HIV-infected patients by liquid chromatography-tandem mass spectrometry.
  Analytical and bioanalytical chemistry 2011 Huang Y, Yang Q, Yoon K, Lei Y, Shi R, Gee W, Lin ET, Greenblatt RM, Gandhi M
• Analysis of pharmacogenetic traits in two distinct South African populations.
  Human genomics 2011 Ikediobi O, Aouizerat B, Xiao Y, Gandhi M, Gebhardt S, Warnich L
• Treatment switching in South Indian patients on HAART: what are the predictors and consequences?
  AIDS care 2011 Chandy S, Singh G, Heylen E, Gandhi M, Ekstrand ML
• Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting.
  Journal of acquired immune deficiency syndromes (1999) 2011 van Zyl GU, van Mens TE, McIlleron H, Zeier M, Nachega JB, Decloedt E, Malavazzi C, Smith P, Huang Y, van der Merwe L, Gandhi M, Maartens G
• Validation of a visual function and quality of life instrument in an urban Indian population with uncorrected refractive error using Rasch analysis.
  Ophthalmic epidemiology 2010 Brady CJ, Keay L, Villanti A, Ali FS, Gandhi M, Massof RW, Friedman DS
• Erratum: Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry.
  Rapid Communications in Mass Spectrometry 2010 Yong Huang, Monica Gandhi, Ruth M. Greenblatt, Winnie Gee, Emil T. Lin, Nicholas Messenkoff
• A randomized clinical trial to evaluate ready-made spectacles in an adult population in India.
  International journal of epidemiology 2010 Keay L, Gandhi M, Brady C, Ali FS, Mathur U, Munoz B, Friedman DS
• The Feminization of an Epidemic: HIV in Women (chapter 37). In Fundamentals of Global HIV Medicine. Temesgen Z, Ed
  The Feminization of an Epidemic: HIV in Women (chapter 37). In Fundamentals of Global HIV Medicine. Temesgen Z, Ed. 2010 Wong EB and Gandhi M.
• Disclosure of complementary and alternative medicine use to health care providers among HIV-infected women.
  AIDS patient care and STDs 2009 Liu C, Yang Y, Gange SJ, Weber K, Sharp GB, Wilson TE, Levine A, Robison E, Goparaju L, Gandhi M, Ganhdi M, Merenstein D
• The feminization of an epidemic. Women and HIV in the United States.
  Positively aware : the monthly journal of the Test Positive Aware Network 2009 Iobst S, Gandhi M
• Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women.
  Journal of acquired immune deficiency syndromes (1999) 2009 Gandhi M, Benet LZ, Bacchetti P, Kalinowski A, Anastos K, Wolfe AR, Young M, Cohen M, Minkoff H, Gange SJ, Greenblatt RM, Women's Interagency HIV Study
• Association of child care burden and household composition with adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study.
  AIDS patient care and STDs 2009 Merenstein D, Schneider MF, Cox C, Schwartz R, Weber K, Robison E, Gandhi M, Richardson J, Plankey MW
• Protease inhibitor levels in hair strongly predict virologic response to treatment.
  AIDS (London, England) 2009 Gandhi M, Ameli N, Bacchetti P, Gange SJ, Anastos K, Levine A, Hyman CL, Cohen M, Young M, Huang Y, Greenblatt RM, Women's Interagency HIV Study (WIHS)
• Positively Aware periodical
  Positively Aware periodical 2009 Iobst S and Gandhi M. Women and HIV in the United States (feature article)
• Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry.
  Rapid communications in mass spectrometry : RCM 2008 Huang Y, Gandhi M, Greenblatt RM, Gee W, Lin ET, Messenkoff N
• Association of complementary and alternative medicine use with highly active antiretroviral therapy initiation.
  Alternative therapies in health and medicine 2008 Merenstein D, Yang Y, Schneider MF, Goparaju L, Weber K, Sharma A, Levine AM, Sharp GB, Gandhi M, Liu C
• Highly active antiretroviral therapy reduces urinary albumin excretion in women with HIV infection.
  Journal of acquired immune deficiency syndromes (1999) 2008 Szczech LA, Golub ET, Springer G, Augenbraun M, Young M, Gandhi M, Gillepsie BS, Anastos K
• Association between living with children and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study.
  Pediatrics 2008 Merenstein DJ, Schneider MF, Cox C, Schwartz R, Weber K, Robison E, Gandhi M, Richardson J, Plankey MW
• Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008 Golub ET, Benning L, Sharma A, Gandhi M, Cohen MH, Young M, Gange SJ
• Association between complementary and alternative medicine use and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study.
  Journal of alternative and complementary medicine (New York, N.Y.) 2007 Liu C, Lerch V, Weber K, Schneider MF, Sharp GB, Gorapaju L, Sharma A, Levine A, Gandhi M, Merenstein D
• Poverty, unstable housing, and HIV infection among women living in the United States.
  Current HIV/AIDS reports 2007 Riley ED, Gandhi M, Hare C, Cohen J, Hwang S
• Acquisition of new sexual partners among women with HIV infection: patterns of disclosure and sexual behavior within new partnerships.
  AIDS education and prevention : official publication of the International Society for AIDS Education 2007 Wilson TE, Feldman J, Vega MY, Gandhi M, Richardson J, Cohen MH, McKaig R, Ostrow D, Robison E, Gange SJ
• Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study.
  American journal of public health 2006 Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, Watts DH, Gandhi M, Mocharnuk RS, Anastos K
• Septic Arthritis and Disseminated Gonococcal Infection (chapter). In Current Rheumatology: Diagnosis and Treatment
  Septic Arthritis and Disseminated Gonococcal Infection (chapter). In Current Rheumatology: Diagnosis and Treatment 2006 Gandhi M and Jacobs RA.
• Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols.
  AIDS (London, England) 2005 Gandhi M, Ameli N, Bacchetti P, Sharp GB, French AL, Young M, Gange SJ, Anastos K, Holman S, Levine A, Greenblatt RM
• Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004 Silverberg MJ, Gore ME, French AL, Gandhi M, Glesby MJ, Kovacs A, Wilson TE, Young MA, Gange SJ
• Journal of Dental Research
  Salivary shedding of human herpesvirus-8 among HIV-infected women is more frequent at higher CD4 cell counts 2004 Gandhi M, Koelle D, Ameli N, Bacchetti P, Greenspan J, Navazesh M, Anastos K, Greenblatt RM
• Sex differences in pharmacokinetics and pharmacodynamics.
  Annual review of pharmacology and toxicology 2004 Gandhi M, Aweeka F, Greenblatt RM, Blaschke TF
• Epidemiology and Natural History of HIV Infection in Women (chapter). In A Guide to the Clinical Care of Women with HIV, Health Resources and Administrations Services (HRSA)
  Epidemiology and Natural History of HIV Infection in Women (chapter). In A Guide to the Clinical Care of Women with HIV, Health Resources and Administrations Services (HRSA) 2003 Hessol N, Gandhi M, and RM Greenblatt.
• Human Herpesvirus 8, Kaposi’s Sarcoma, and Associated Conditions (Review). Clinics in Laboratory Medicine
  Human Herpesvirus 8, Kaposi’s Sarcoma, and Associated Conditions (Review). Clinics in Laboratory Medicine. 2002 Gandhi M and RM Greenblatt.
• Human herpesvirus 8, Kaposi's sarcoma, and associated conditions.
  Clinics in laboratory medicine 2002 Gandhi M, Greenblatt RM